Scientists probe lung tissue to unlock secrets of scarring disease
NCT ID NCT00515567
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects lung tissue from patients awaiting a lung transplant to learn more about pulmonary fibrosis at the cellular level. Researchers will examine cells and proteins linked to the disease. About 90 participants will provide tissue samples, but no experimental treatment is given. The goal is to better understand what causes the disease, not to test a new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI catch lung scarring that doctors might miss?
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- AI reads lung scans to predict who will get worse
- How safe is bronchoscopy for ILD patients? new study aims to find out
- New approach to CPR talks may help patients and families feel heard
- Can a breath test predict lung scarring? new study seeks answers